Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PBM
PBM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PBM News
Psyence BioMed Successfully Exports GMP-Compliant Psychedelic Product
Mar 03 2026
Newsfilter
Vanda Pharmaceuticals Shares Surge 33% in Pre-Market Trading
Feb 23 2026
Benzinga
Psyence BioMed Exercises Put Option to Invest in PsyLabs
Feb 20 2026
Newsfilter
Psyence BioMed Announces Shareholder Meeting Voting Results
Feb 17 2026
Newsfilter
Psyence BioMed Enters Put Option Agreement with PsyLabs
Feb 13 2026
Newsfilter
Psyence Biomedical Settles Shareholder Claim for $1.5 Million
Feb 11 2026
Newsfilter
PSYENCE BIOMEDICAL LTD TO PAY KAOS CAPITAL $1.5 MILLION IN SETTLEMENT
Feb 11 2026
moomoo
Teradyne Q4 Earnings Beat Estimates, Shares Surge
Feb 03 2026
Benzinga
Psyence Biomedical Delays Reverse Stock Split Implementation
Feb 02 2026
stocktwits
Psyence BioMed Announces Share Consolidation Plan
Jan 28 2026
Newsfilter
Psyence Biomedical (PBM) Announces 1-for-6.25 Reverse Stock Split Effective January 20, 2026
Jan 15 2026
seekingalpha
Psyence BioMed Executes 1-for-6.25 Share Consolidation, Reducing Outstanding Shares to 1.02 Million
Jan 15 2026
Globenewswire
Psyence Biomedical Approves 2026 Financial Strategy and Share Repurchase Program
Jan 12 2026
Newsfilter
Psyence BioMed Becomes First Nasdaq Company to Produce GMP-Compliant Ibogaine HCl
Jan 05 2026
Globenewswire
Psyence BioMed Achieves First GMP-Compliant High-Purity Ibogaine Production on Nasdaq
Jan 05 2026
Newsfilter
Kraig Biocraft Laboratories Transitions to Spider Silk Commercialization with 22% Yield Increase
Dec 19 2025
Newsfilter
Show More News
